Clinical analysis for the short-term outcome of Da Vinci robotic-assisted left upper lobectomy for lung cancer
- VernacularTitle:达芬奇机器人左肺上叶切除术治疗肺癌的近期临床效果分析
- Author:
TONG Liping
1
,
2
;
ZHENG Xiaoqing
1
,
2
;
DUAN Hongtao
1
,
2
;
LIU Honggang
1
,
2
;
DONG Xiaoping
1
,
2
;
ZHANG Yong
1
,
2
;
YAN Xiaolong
1
,
2
Author Information
1. Department of Thoracic Surgery, Tangdu Hospital, Air Force Medical University, Xi'
2. an, 710038, P.R.China
- Publication Type:Journal Article
- Keywords:
Lung cancer;
minimally invasive;
Da Vinci surgical system;
left upper lobectomy
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2020;27(02):183-189
- CountryChina
- Language:Chinese
-
Abstract:
Objective To summarize the clinical experience of Da Vinci robotic-assisted left upper lobectomy for treating lung cancer. Methods We retrospectively analyzed the perioperative data of 33 patients with primary lung cancer who underwent Da Vinci robotic-assisted left upper lobectomy between December 2016 and December 2018 in our hospital. Meanwhile, the perioperative data of 41 patients with lung cancer who underwent video-assisted thoracoscopic left upper lobectomy during the same period by the same surgeon were studied as a control group. The resection was followed by the principle of "from back down to front up" way. Systemic lymph node dissection including No.4-9 was performed for all patients. Results All patients received successful surgery with no case of conversion to thoracotomy and perioperative death. Comparing to video-assisted thoracoscopic surgery, the Da Vinci robotic-assisted left upper lobectomy had longer operating time (191.21±61.77 min vs. 154.51±38.81 min, P=0.003), more cost (82 307.75±11 859.03 yuan vs. 58 966.57±5 640.07 yuan, P=0.000), shorter chest tube duration (4.58±1.77 d vs. 5.41±1.52 d, P=0.031) and postoperative hospital stay (6.48±1.82 d vs. 7.66±2.12 d, P=0.014). However, there was no significant difference between the two groups regarding to blood loss, lymph node dissection, postoperative pain score, total chest drainage volume, chest drainage volume per day and the rate of pulmonary complications. Conclusion The Da Vinci robotic-assisted left upper lobectomy for treating lung cancer is safe and more minimally invasive, but more expensive.
